was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
Senior Director, US Oncology Product, Pipeline and Patient Communications & Advocacy Location: Philadelphia, PA | Durham, NC The Senior Director, US Oncology Product, Pipeline and Patient Communications & Advocacy is responsible for lea...
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highly mission-driven in our unrelenting commit...
Position Summary The Program Operational Readiness Senior Director is accountable for leading the operational readiness strategy and governance required to transition a major program from project delivery into safe, compliant, and effecti...
Territory includes but is not limited to Fort Myers The Hospital Senior Account Manager supports and advances formulary access, protocol and order set readiness, discharge pathway support, and demand generation across targeted hospital ac...
​As a Process Operator you will operates, challenges and cleans equipment, according to appropriate SOPs, JSAs, and batch documents to deliver high quality products manufactured in a safe way to fulfil the needs of the supply chain. You wil...
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our po...
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our p...
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our ...
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our u...